Bio Green Med Solution, Inc. (BGMS) stock price, financials & research

Regular session · ET · Market data may be delayed.

GoAI snapshot

Jul 10, 2026

44/ 100

GoAI Score

Hold

Valuation

70

Undervalued

Sentiment

49

Mixed

Risk

63

High Risk

Momentum

24

Weakening

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

Company profile

Company website

Bio Green Med Solution, Inc. (BGMS) operates as a multifaceted company, with active involvement in both the fire protection and biopharmaceutical industries. The organization recently broadened its capabilities by completing the acquisition of Fitters Sdn. Bhd., a Malaysian firm known for its fire safety products and services. BGMS is committed to driving progress in biopharmaceutical research and developing cutting-edge fire safety solutions, striving to deliver enduring value to its investors.

Industry: Medical - Pharmaceuticals
Sector: Healthcare
Headquarters: MY
CEO: Sing Ee Wong
Listed since: Sep 12, 2025
Employees: 12

Market position

Day range

Current $0.849

$0.80$0.85

52-week range

Current $0.849

$0.5664$6.70

Open: $0.80
Previous close: $0.821
Volume: 10.72K; 0× average
Average volume: 2.32M; Average daily volume
Market cap: 4.69M USD
Beta: -0.38; Market reference 1
50-day average: $0.9026; -5.94% below average
200-day average: $1.0028; -15.34% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

P/E (TTM): -0.23×
P/B (TTM): 0.66×
P/S (TTM): 2.52×
Dividend yield: 0.00%

Profitability & efficiency

Gross margin: 19.34%
Operating margin: -147.13%
Net margin: -118.27%

Financial health

Debt / equity: 0×

BGMS news

globenewswire.comSep 30, 2026

$HAREHOLDER ALERT - The M&A Class Action Firm Continues to Investigate the Merger— ATKR, BZH, BGMS and CBAN

NEW YORK, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a…

Read source

defenseworld.netSep 28, 2026

Cyclacel Pharmaceuticals, Inc. (NASDAQ:BGMS) Shares Shorted: Short Interest Up 160.2% in September

Cyclacel Pharmaceuticals, Inc. (NASDAQ: BGMS - Get Free Report) saw a large growth in short interest in the month of September. As of September 15th, there was short interest totaling 90,785 shares, a growth of 160.2%…

Read source

globenewswire.comSep 8, 2026

EQUITY ALERT: The M&A Class Action Firm Launches Inquiry for the Merger— ATKR, BGMS, BOW and FTHM

NEW YORK, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a…

Read source

globenewswire.comAug 12, 2026

BIO GREEN MED SOLUTION REPORTS SECOND QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

KUALA LUMPUR, MALAYSIA, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (NASDAQ: BGMS; "BGMS" or the "Company"), a diversified company engaged primarily in the provision of fire safety protection and…

Read source

prnewswire.comJul 27, 2026

Are FBRX, ACA, BGMS Obtaining Fair Deals for their Shareholders?

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws

Read source

defenseworld.netJul 26, 2026

Financial Review: Peak Pharmaceuticals (OTCMKTS:PKPH) versus Cyclacel Pharmaceuticals (NASDAQ:BGMS)

Cyclacel Pharmaceuticals (NASDAQ: BGMS - Get Free Report) and Peak Pharmaceuticals (OTCMKTS:PKPH - Get Free Report) are both small-cap manufacturing companies, but which is the superior business? We will contrast the two…

Read source

BGMS peers

AMGN

Amgen Inc.

$414.87

+1.82%

GILD

Gilead Sciences, Inc.

$151.17

+2.77%

ISRG

Intuitive Surgical, Inc.

$423.96

+2.06%

VRTX

Vertex Pharmaceuticals Incorporated

$510.08

+1.36%

SNY

Sanofi

$40.07

-0.40%

MRNA

Moderna, Inc.

$225

+14.21%

Bio Green Med Solution, Inc.

BGMS company overview

Company profile

Bio Green Med Solution, Inc.

BGMS company overview

GoAI snapshot

Company profile

Market position

Financials

Financial snapshot

Valuation & yield

Profitability & efficiency

Financial health

BGMS news

$HAREHOLDER ALERT - The M&A Class Action Firm Continues to Investigate the Merger— ATKR, BZH, BGMS and CBAN

Cyclacel Pharmaceuticals, Inc. (NASDAQ:BGMS) Shares Shorted: Short Interest Up 160.2% in September

EQUITY ALERT: The M&A Class Action Firm Launches Inquiry for the Merger— ATKR, BGMS, BOW and FTHM

BIO GREEN MED SOLUTION REPORTS SECOND QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

Are FBRX, ACA, BGMS Obtaining Fair Deals for their Shareholders?

Financial Review: Peak Pharmaceuticals (OTCMKTS:PKPH) versus Cyclacel Pharmaceuticals (NASDAQ:BGMS)

BGMS peers

Continue in GoAI

BGMS company overview

Company profile

Market position

BGMS company overview

Company profile

BGMS company overview

Company profile

Market position

BGMS company overview

GoAI snapshot

Company profile

Market position

Financials

Financial snapshot

Valuation & yield

Profitability & efficiency

Financial health

BGMS news

$HAREHOLDER ALERT - The M&A Class Action Firm Continues to Investigate the Merger— ATKR, BZH, BGMS and CBAN

Cyclacel Pharmaceuticals, Inc. (NASDAQ:BGMS) Shares Shorted: Short Interest Up 160.2% in September

EQUITY ALERT: The M&A Class Action Firm Launches Inquiry for the Merger— ATKR, BGMS, BOW and FTHM

BIO GREEN MED SOLUTION REPORTS SECOND QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

Are FBRX, ACA, BGMS Obtaining Fair Deals for their Shareholders?

Financial Review: Peak Pharmaceuticals (OTCMKTS:PKPH) versus Cyclacel Pharmaceuticals (NASDAQ:BGMS)

BGMS peers

Continue in GoAI